Mammatyper logo
icon_theraphy_mammatyper_patient

Patient Therapy

In recent years numerous life-saving treatment options have been developed for the therapy of Breast Cancer. Today there is a wide selection of treatments available to fight each individual Breast Cancer type. For a personalized treatment recommendation different approaches are selected and combined based on a sound diagnosis. Clinical parameters guide the oncologist in assessing the suitable intervention e.g.:

therapy-pathways

Subtype

Systemic Therapy

Benefits of MammaTyper®

Luminal A-like

Endocrine therapy

Based on accurate measurement MammaTyper® supports differentiation of low risk Luminal A-like from high risk Luminal B-like by precise and reproducible MKI67 determination

Luminal B-like (HER2 negative)

Endocrine therapy + Cytotoxics

Accurate determination of hormone receptor > endocrine responder or non –responder Precise differentiation of low risk Luminal A-like from high risk Luminal B-like by accurate and reproducible MKI67 determination by MammaTyper®

Luminal B-like (HER2 positive)

Endocrine therapy + Cytotoxics + Anti-HER2

Accurate determination of hormone receptor expression by MammaTyper® > endocrine responder or non –responder Accurate determination of ERBB2 expression by MammaTyper®

HER2 positive (non-luminal)

Anti-HER2

Accurate determination of ERBB2 expression by MammaTyper®

Triple negative (ductal)

Cytotoxics

Accurate determination of ERBB2, ESR1, PGR expression negativity by MammaTyper®